Asian Pacific Journal of Allergy and Immunology

  • HOME
  • ABOUT
  • EDITORS
  • SUBMISSION
    • Online Submission
    • Author Instructions
  • ISSUE
    • Current
    • Early Online
    • Archives
  • PERMISSIONS
  • CONTACT
  • ADVERTISE
Home
 / 
Original Article
 / 
Recurrence rate and risk factors of recurrent anaphylaxis: A ten-year retrospective cohort study

July 2, 2025
Original Article

Recurrence rate and risk factors of recurrent anaphylaxis: A ten-year retrospective cohort study

Suwannee Uthaisangsook,1 Nadda Padsee,1 Sagoontee Inkate2

Affiliations:
1 Department of Pediatrics, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand
2 Faculty of Medicine, Naresuan University, Phitsanulok, Thailand

Abstract

Background: Few studies have investigated the risk factors for recurrent anaphylaxis. Identifying these factors may help patients implement preventive measures.
Objective: To determine the rate and risk factors for recurrent anaphylaxis, assess the time to recurrence, and compare the characteristics, triggers, and clinical manifestations between recurrent and non-recurrent cases.
Methods: A retrospective cohort study was conducted at Naresuan University Hospital from March 2011 to February 2021, using medical records of patients with ICD-10–confirmed anaphylaxis. Risk factors for recurrence were analyzed using Cox proportional hazards regression model.
Results: A total of 439 anaphylactic episodes were identified in 381 patients (49 children, 332 adults). Of these, 42 patients (11.2%) experienced 58 recurrent episodes (7/49 [14.3%] children, 35/332 [10.6%] adults). Food and medications were the most and second most common triggers. The median time to recurrence was 9.9 months (IQR: 3.1–18.8), while the median follow-up duration for non-recurrent cases was 41.8 months (IQR: 23.8–61.8). The recurrent anaphylaxis rate was 4.1 events per 100 person-years. Statistically significant risk factors included a history of food, a history of insect, a history of drug allergies, chest discomfort, and severe anaphylaxis (HR [95%CI]: 3.31 [1.50-7.29], p = 0.003; 4.96 [1.47–16.82], p = 0.010; 5.87 [2.64–13.07], p < 0.001; 2.43 [1.19-4.99], p = 0.015; and 2.29 [1.07-4.88], p = 0.033, respectively). Conversely, palpitations were associated with a lower risk of recurrence (HR 0.11 [0.01–0.86], p = 0.036).
Conclusion: Identifying risk factors in anaphylaxis patients enhances medical care and aids in preventing recurrence.

Full Text
Vol. 44, No. 3

Allergy, Recurrent anaphylaxis, recurrent rate, risk factors, Thailand

Categories

  • Announcement (1)
  • Case Report (23)
  • Early Online (101)
  • Original Article (240)
  • Review Article (30)

Key words

allergen allergic diseases Allergic rhinitis Allergy Anaphylaxis Asthma atopic dermatitis child Children chronic rhinosinusitis chronic spontaneous urticaria Chronic Urticaria COVID-19 COVID-19 vaccine depression diagnosis drug allergy Drug hypersensitivity efficacy Epidemiology food allergy house dust mite IgE Immunotherapy obstructive sleep apnea Omalizumab prevalence Quality of life Questionnaire Reliability risk factor risk factors safety SARS-CoV-2 Sensitization Severe asthma Skin prick test Specific IgE subcutaneous immunotherapy Sublingual immunotherapy Thai treatment urticaria vaccine Vitamin D
Asian Pacific Journal of Allergy and Immunology

Support Contact

Managing Editor
Ms. Patrawadee Pitakpolrat
E-mail: managingeditor@apjai-journal.org

Production Editor
Ms. Chanita Jangsawang
E-mail: chanita.j@apjai-journal.org

Asian Pacific Journal of Allergy and Immunology © 2026 All rights reserved.
All rights reserved | Privacy Policy